Breaking News Bar

Business News and Information

Central Nervous System (CNC) Market 2017 CNS Cluster Addiction Drug Development Pipeline Review

Latest market research report on "CNS Cluster Addiction Drug Development Pipeline Review, 2017" published at orbisresearch.com

Central Nervous System (CNC) Market 2017 CNS Cluster Addiction Drug Development Pipeline Review

Dallas, United States - May 18, 2017 /MarketersMedia/

The central nervous system (CNS) addiction cluster report provides an overview of the CNS Clusters pipeline landscape. The report provides comprehensive information on the therapeutics under development, and key players involved in therapeutic development for Alcohol Addiction, Drug Addiction, Nicotine Addiction, Opium (Opioid) Addiction and features dormant and discontinued projects.

Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decreased involvement in extracurricular activities, depression, restlessness, inability to control drinking and violent behavior. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Nicotine addiction also called tobacco dependence is an addiction to tobacco products caused by the drug nicotine. Finally, opioid addiction develops after using opioids regularly for a period of time. Prolonged use of opiates can lead to nerve damage within the brain that causes cells to stop producing endogenous opiates (natural painkillers known as endorphins).

The size of these pipelines ranges from 19 in nicotine addiction to 67 in drug addiction, with a substantial degree of overlap between these indications in terms of the key players and the types of molecular target which are being studied. The mu and kappa-opioid receptors are the dominant molecular target across alcohol, drug and opioid addiction, and other neurotransmitter receptors such as the cannabinoid and dopamine receptors are common molecular targets across the three.

Scope
- Which companies are the most active within the pipeline for addiction therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of addiction therapeutics?

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/289232 .

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Purchase a single user copy @ http://www.orbisresearch.com/contact/purchase/289232.

Table of Contents:
Table of Contents
GBI Research Report Guidance 2
Executive Summary 3
Table of Contents 4
List of Tables 6
List of Figures 9
Introduction 10
CNS Cluster Addiction Report Coverage 10
Alcohol Addiction – Overview 10
Drug Addiction – Overview 10
Nicotine Addiction – Overview 10
Opium (Opioid) Addiction – Overview 10
Therapeutics Development 11
Alcohol Addiction 11
Drug Addiction 17
Nicotine Addiction 25
Opium (Opioid) Addiction 28
Therapeutics Assessment 34
Alcohol Addiction 34
Drug Addiction 41
Nicotine Addiction 50
Opium (Opioid) Addiction 56
Companies Involved in Therapeutics Development 65
Alcohol Addiction 65
Drug Addiction 78
Nicotine Addiction 90
Opium (Opioid) Addiction 94
Dormant Projects 104
Alcohol Addiction 104
Drug Addiction 106
Nicotine Addiction 108
Opium (Opioid) Addiction 109
Discontinued Products 110
Alcohol Addiction 110
Drug Addiction 110
Nicotine Addiction 110
Opium (Opioid) Addiction 111
Product Development Milestones 112
Alcohol Addiction 112
Drug Addiction 123
Nicotine Addiction 134
Opium (Opioid) Addiction 137
Appendix 149
Methodology 149
Coverage 149
Secondary Research 149
Primary Research 149
Expert Panel Validation 149
Contact Us 149
Disclaimer 150

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600
Phone: +1 (214) 884-6817

Source URL: http://marketersmedia.com/central-nervous-system-cnc-market-2017-cns-cluster-addiction-drug-development-pipeline-review/200965

For more information, please visit http://www.orbisresearch.com/reports/index/cns-cluster-addiction-drug-development-pipeline-review-2017

Source: MarketersMedia

Release ID: 200965

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear